StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of CALA stock opened at $0.01 on Friday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.13. The firm’s 50 day moving average is $0.02 and its 200 day moving average is $0.02.
Calithera Biosciences Company Profile
See Also
- Five stocks we like better than Calithera Biosciences
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Average 401k Balance by Age Explained
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20211130090720&h=45&w=95&zc=2){kind=logo}
